ASP Isotopes Inc. (NASDAQ:ASPI) COO Robert Ainscow Sells 66,668 Shares of Stock

ASP Isotopes Inc. (NASDAQ:ASPI) COO Robert Ainscow sold 66,668 shares of the company’s stock in a transaction dated Thursday, April 17th. The shares were sold at an average price of $5.62, for a total transaction of $374,674.16. Following the completion of the transaction, the chief operating officer now owns 1,419,992 shares in the company, valued at approximately $7,980,355.04. This trade represents a 4.48 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Robert Ainscow also recently made the following trade(s):

• On Tuesday, April 15th, Robert Ainscow sold 66,666 shares of ASP Isotopes stock. The shares were sold at an average price of $5.75, for a total value of $383,329.50.

ASP Isotopes Stock Performance

Shares of NASDAQ:ASPI opened at $5.84 on Friday. ASP Isotopes Inc. has a 12-month low of $1.86 and a 12-month high of $9.33. The company’s 50 day moving average price is $4.74 and its two-hundred day moving average price is $5.15. The firm has a market cap of $420.88 million, a PE ratio of -9.57 and a beta of 3.44. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80.

Hedge Funds Weigh In On ASP Isotopes

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD grew its stake in shares of ASP Isotopes by 14.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 21,646 shares of the company’s stock worth $99,000 after buying an additional 2,757 shares during the last quarter. Russell Investments Group Ltd. grew its position in ASP Isotopes by 56.3% during the 4th quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company’s stock worth $46,000 after acquiring an additional 3,682 shares during the last quarter. Rhumbline Advisers increased its holdings in ASP Isotopes by 8.2% in the 1st quarter. Rhumbline Advisers now owns 65,326 shares of the company’s stock worth $306,000 after purchasing an additional 4,963 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in ASP Isotopes by 31.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 22,196 shares of the company’s stock worth $62,000 after purchasing an additional 5,307 shares in the last quarter. Finally, Hanson & Doremus Investment Management bought a new position in ASP Isotopes in the fourth quarter valued at about $27,000. Institutional investors own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.